MHRA Approves Dovonex Psoriasis Ointment

August 29, 2017

 The UK Medicines and Healthcare products Regulatory Agency has approved Dovonex for psoriasis treatment.

The ointment will be available to adults over 18 without a prescription after a consultation with a pharmacist to diagnosed psoriasis patients. The product can be used up to 12 weeks, after which patients are advised to consult a doctor.

The ointment, containing vitamin D analog calcipotriol, will be provided in 60g tubes.

View today's stories